OPKO Health Inc (OPK.N)

OPK.N on New York Stock Exchange

1:33am IST
Change (% chg)

$0.39 (+3.88%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for OPK.N


OPKO Health, Inc. (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment... (more)


Beta: 1.42
Market Cap(Mil.): $5,501.82
Shares Outstanding(Mil.): 547.44
Dividend: --
Yield (%): --


  OPK.N Industry Sector
P/E (TTM): 72.11 34.43 35.43
EPS (TTM): 0.14 -- --
ROI: 4.26 13.73 13.09
ROE: 5.33 14.71 14.22

BRIEF-Opko Health reports Q1 loss per share $0.02

* Q1 earnings per share view $-0.03, revenue view $266.3 million -- Thomson Reuters I/B/E/S

10 May 2016

BRIEF-Opko Health unit and Vifor Fresenius Medical Care enter into development and license deal

* Co's unit and Vifor Fresenius Medical Care Pharma entered into development and license deal for development and marketing of Rayaldee

09 May 2016

BRIEF-OPKO Health presents additional data on rayaldee

* Data showed that mean plasma levels of iPTH and other markers of elevated bone metabolism gradually fell with rayaldee treatment Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

01 Apr 2016

BRIEF-Opko health provides additional data on kidney drug

* Presents additional data on rayaldee to treat secondary hyperparathyroidism in chronic kidney disease

31 Mar 2016

BRIEF-OPKO receives complete response letter from FDA for Rayaldee new drug application

* Opko Health Inc - Opko receives complete response letter from fda for rayaldee new drug application

30 Mar 2016


Earnings vs. Estimates